These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12400132)

  • 1. [A variant of monotherapy in vertigo and subjective noise in the ears].
    Golubovskiĭ OA; Fedorova OV
    Vestn Otorinolaringol; 2002; (4):34-5. PubMed ID: 12400132
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of betaserk in combined treatment of neurosensory hypoacusis and vestibulopathy in childhood].
    Chistiakova VR
    Vestn Otorinolaringol; 2004; (2):9-12. PubMed ID: 15111941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of vertigo with betahistine and its clinical and electrophysiological evaluation].
    Wasilewska H; Domzał TM
    Neurol Neurochir Pol; 1999; 33(1):63-9. PubMed ID: 10399725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study.
    Novotný M; Kostrica R
    Int Tinnitus J; 2002; 8(2):115-23. PubMed ID: 14763223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of betahistine dihydrochloride effectiveness in the treatment of disturbance of balance system, based on analysis of doctors and patients questionnaires results].
    Jurkiewicz D; Kantor I; Usowski J
    Pol Merkur Lekarski; 2006; 21 Suppl 1():3-12. PubMed ID: 17469244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betahistine: hallucinations?
    Prescrire Int; 2015 Nov; 24(165):269. PubMed ID: 26688903
    [No Abstract]   [Full Text] [Related]  

  • 7. Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action.
    Lacour M; Sterkers O
    CNS Drugs; 2001; 15(11):853-70. PubMed ID: 11700150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Betaserc and improvement of life quality in war veterans].
    Larikova TI; Cherevikova GM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(3):68-70. PubMed ID: 15822746
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experiences with betahistine].
    Müller H; Buttkus R
    Laryngol Rhinol Otol (Stuttg); 1983 Apr; 62(4):151-3. PubMed ID: 6602925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of idiopathic sudden sensorineural hearing loss: experience in newly developing Qatar.
    Salahaldin AH; Bener A; ElHakeem AA; Abdulhadi K
    Int Tinnitus J; 2004; 10(2):165-9. PubMed ID: 15732516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A use of betaserc in ataxic syndromes].
    Prokopenko SV; Rudnev VA; Afanas'eva EV; Abramov VG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):41-5. PubMed ID: 15554141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of betahistine on the function of equilibrium system].
    Kubiczkowa J
    Otolaryngol Pol; 1997; 51 Suppl 25():230-9. PubMed ID: 9757700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of betahistine in the treatment of peripheral vertigo.
    Ramos Alcocer R; Ledezma Rodríguez JG; Navas Romero A; Cardenas Nuñez JL; Rodríguez Montoya V; Deschamps JJ; Liviac Ticse JA
    Acta Otolaryngol; 2015; 135(12):1205-11. PubMed ID: 26245698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Betaserk in therapy of cochleovestibular disordes].
    Khrapko NS; Sedykh MI; As'kova LN; Tarasova NV; Velikanov AK; Baryshevskaia LA
    Vestn Otorinolaringol; 2006; (4):59-60. PubMed ID: 17152479
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vertigo: patient management tactics].
    Vasyl'chuk IS; Kozlova OO; Trinus KF; Holovchenko IuI; Slobodin TM
    Lik Sprava; 2012; (7):84-7. PubMed ID: 23350121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo.
    Albera R; Ciuffolotti R; Di Cicco M; De Benedittis G; Grazioli I; Melzi G; Mira E; Pallestrini E; Passali D; Serra A; Vicini C
    Acta Otolaryngol; 2003 Jun; 123(5):588-93. PubMed ID: 12875580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Betaserk efficiency in cochlear and vestibular disorders in the regional surdocenter].
    Pekaskiĭ SI
    Vestn Otorinolaringol; 2001; (3):61. PubMed ID: 11510053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effectiveness of maneuvers and medication in the treatment of benign paroxysmal positional vertigo.
    Itaya T; Yamamoto E; Kitano H; Yazawa Y; Kitajima K
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(3):155-8. PubMed ID: 9186970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiology, clinical features and betaserc therapy of vertigo in initial and reversible cerebrovascular pathology].
    Gornostaeva GV; Varakin IuIa; Prokopovich ME; Alekseeva NS; Fedin PA; Chechetkin AO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(9):14-7. PubMed ID: 16250576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of betaserk in experimental motor disease].
    Mantsev EI; Sigaleva EE
    Vestn Otorinolaringol; 2005; (6):49-52. PubMed ID: 16353011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.